Promotora Outreach for Cervical Cancer Screening

促进癌症研究的伙伴关系：NMSU和FHCRC(第1/2) 试点项目5：促进宫颈癌筛查外展 雨果·维尔奇斯(NMSU)/贝蒂·汤普森(Beti Thompson) 摘要 摘要 美国的西班牙裔女性(美国)浸润性宫颈癌的发病率几乎翻了一番 非西班牙裔白人所经历的。这个问题在美国边境社区尤为严重。 还有墨西哥。巴氏试验(Pap)用于早期宫颈病变检测的流行率差异如下 认为，部分是为了解释发病率的差异，然而，参与后续护理的差异 在宫颈细胞学检查异常的女性中，这一差异也可能是原因之一。总体目标 这一外展项目的主要目的是增加对异常纸片涂片的纸片检测和后续检测 居住在新墨西哥州和墨西哥边境社区的妇女。具体地说，使用Promotora计划 为了促进纸片检测和异常检测的跟进，我们将： 1.首先，增加在特定边境社区诊所进行的PAP检测次数，而不是 两个不干预诊所；以及 二是提高边疆专科门诊宫颈涂片异常随访率。 在干预诊所工作的推动者将接受培训，向他们提供信息并鼓励 妇女将接受纸片检测。他们还将接受培训，与诊所合作，以确定测试结果 并鼓励检测异常的妇女接受后续检测。最后，他们会将女性介绍给 如果第一次或后续检查呈阴性，通常会给予护理，如果妇女出现 宫颈癌。社区中有许多治疗宫颈癌妇女的机构。主 与我们的具体目标相对应的感兴趣的问题有：1)。纸片检测结果是否增加 干预？和2)。是否有更多的后续检查(例如，重复检查或阴道镜检查)作为结果 干预？第二个目的是回答问题3)：治疗宫颈病变的模式(S)是什么？ 癌症？在这个为期三年项目的前六个月，将收集有关现有纸质考试的信息 将参与的三家诊所的费率。接下来的24个月将包括在一家诊所进行干预 提高试纸筛查率和异常检测随访率，并遵循治疗模式。在.期间 在最后6个月，我们将评估论文筛查和异常论文随访率的差异。

Partnership for the Advancement of Cancer Research: NMSU & FHCRC (1 of 2) Pilot Project #5: Promotora outreach for cervical cancer screening Hugo Vilchis (NMSU) / Beti Thompson (FHCRC) ABSTRACT ABSTRACT Hispanic women in the United States (U.S.) experience nearly double the incidence of invasive cervical cancer experienced by non-Hispanic whites. The problem is especially severe in the border communities of the U.S. and Mexico. Differences in prevalence of Papanicolaou (Pap) tests for early cervical lesion detection are thought, in part, to explain the differences in incidence, however, difference in participation in follow-up care among women with abnormal cervical cytologic findings also may contribute to the disparity. The overall goals of this outreach project are to increase pap testing and follow-up testing for abnormal pap smears among women living in the border communities of New Mexico and Mexico. Specifically, using a promotora program to promote pap testing and follow-up for abnormal tests, we will: 1. Primarily, increase the number of pap tests that occur in a specific border community clinic compared to two non-intervention clinics; and 2. Secondarily, increase the follow-up rates for abnormal pap smears in the specific Border clinic. Promotoras who work with the intervention clinic will be trained to provide information to and encourage women to receive pap testing. They also will be trained to work with the clinic to identify the results of the tests and to encourage women with abnormal tests to receive follow-up testing. Finally, they will refer women to usual care if the initial or follow-up tests are negative or refer women to treatment if the woman presents with cervical cancer. A number of agencies exist in the community to treat women with cervical cancer. The main questions of interest, corresponding to our specific aims are: 1). Is there increased pap testing as a result of the intervention? and 2). Is there increased follow-up testing (e.g., repeat pap or colposcopy) as a result of the intervention? A secondary aim is to answer question 3): What is the pattern(s) for treatment of cervical cancer? During the first six months of this three year project, information will be gathered on existing pap test rates in the three clinics that will participate. The next 24 months will consist of intervention in one clinic to increase pap screening rates and follow-up rates for abnormal tests and to follow treatment patterns. During the final 6 months, we will assess differences in pap screening and abnorma pap follow-up rates.